Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic diseases
3.2.1.2 Growing non-therapeutic application of albumin
3.2.1.3 Increase in demand for albumin in R&D activities
3.2.1.4 Technological advancements in biotechnology
3.2.2 Industry pitfalls & challenges
3.2.2.1 Irrational uses and adverse effects associated with albumin
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Human serum albumin
5.3 Bovine serum albumin
5.4 Recombinant albumin
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Clinical applications
6.2.1 Drug delivery
6.2.2 Emergency treatment of shock
6.2.3 Burn treatment
6.2.4 Intravenous therapy
6.2.5 Other clinical applications
6.3 Drug and device formulation
6.3.1 Drug formulation
6.3.2 Cell culture media ingredients
6.3.3 Vaccine ingredients/stabilization
6.3.4 Other drug and device formulation applications
6.4 Diagnostic applications
6.5 Gene therapy formulation
6.6 Nutritional supplements
6.7 Other applications
Chapter 7 Market Estimates and Forecast, By End-user, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals & clinics
7.3 Pharmaceutical & biotechnology industry
7.4 Research institutes and laboratories
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Albumedix Ltd
9.2 Akron Biotech
9.3 Baxter International Inc.
9.4 Bristol-Myers Squibb Company
9.5 China Biologic Products Holdings Inc.
9.6 CSL Behring LLC
9.7 Grifols (Biotest AG)
9.8 Merck & Co., Inc.
9.9 Octapharma AG
9.10 Thermo Fisher Scientific Inc.
